Oxford BioMedica PLC (OXBDF)

[marcusl2]

more than 2 companies very interested in Prosavin and a lot of interest in Car T 5T4, great!

expecting further Car Ts from Novartis

lots of pre -clinical candidates.

Couple of years ahead of competitors with tech. Expansion will take manuf to similar size as Bluebird.

very positive

JD says they have so many options that they are picking through them to choose the best ones for OXB.

Biov deal, royalties will increase IF.... inaudible !

when Kymriah reaches peak sales, the royalties become as interesting as manufacturing revenue